V Longo1, A Forleo2, S Capone2, E Scoditti3, M A Carluccio3, P Siciliano2, M Massaro4. 1. National Research Council of Italy, Institute for Microelectronics and Microsystems, Lecce, Italy. valentina.longo@le.imm.cnr.it. 2. National Research Council of Italy, Institute for Microelectronics and Microsystems, Lecce, Italy. 3. National Research Council of Italy, Institute of Clinical Physiology, Lecce, Italy. 4. National Research Council of Italy, Institute of Clinical Physiology, Lecce, Italy. marika.massaro@ifc.cnr.it.
Abstract
INTRODUCTION: The evaluation of volatile organic compounds(VOCs) emitted by human body offers a unique tool to set up new non-invasive devices for early diagnosis and long-lasting monitoring of most human diseases. However, their cellular origin and metabolic fate have not been completely elucidated yet, thus limiting their clinical application. Endothelium acts as an interface between blood and surrounding tissues. As such, it adapts its physiology in response to different environmental modifications thus playing a role in the pathogenesis of many metabolic and inflammatory diseases. OBJECTIVES: Since endothelium specifically reshapes its physiologic functions upon environmental changes the objective of this study was to evaluate if and how pro-inflammatory stimuli affect VOC metabolism in endothelial cell in culture. METHODS: Gas chromatography with mass spectrometric detection was applied to profile VOCs in the headspace of cultured endothelial cells (EC) in the absence or presence of the pro-inflammatory stimulus lipopolysaccharide (LPS). RESULTS: We observed that, under resting conditions, EC affected the amount of 58 VOCs belonging to aldehyde, alkane and ketone families. Among these, LPS significantly altered the amount of 15 VOCs. ROC curves show a perfect performance (AUC = 1) for 10 metabolites including 1-butanol, 3-methyl-1-butanol and 2-ethyl-1-hexanol. DISCUSSION: The emission and uptake of the aforementioned VOCs disclose potential unexplored metabolic pathways for EC that deserve to be investigated. Overall, we identified new candidate VOC potentially exploitable, upon experimental confirm in in vivo model of disease, as potential biomarkers of sepsis and pro-inflammatory clinical settings.
INTRODUCTION: The evaluation of volatile organic compounds(VOCs) emitted by human body offers a unique tool to set up new non-invasive devices for early diagnosis and long-lasting monitoring of most human diseases. However, their cellular origin and metabolic fate have not been completely elucidated yet, thus limiting their clinical application. Endothelium acts as an interface between blood and surrounding tissues. As such, it adapts its physiology in response to different environmental modifications thus playing a role in the pathogenesis of many metabolic and inflammatory diseases. OBJECTIVES: Since endothelium specifically reshapes its physiologic functions upon environmental changes the objective of this study was to evaluate if and how pro-inflammatory stimuli affect VOC metabolism in endothelial cell in culture. METHODS: Gas chromatography with mass spectrometric detection was applied to profile VOCs in the headspace of cultured endothelial cells (EC) in the absence or presence of the pro-inflammatory stimulus lipopolysaccharide (LPS). RESULTS: We observed that, under resting conditions, EC affected the amount of 58 VOCs belonging to aldehyde, alkane and ketone families. Among these, LPS significantly altered the amount of 15 VOCs. ROC curves show a perfect performance (AUC = 1) for 10 metabolites including 1-butanol, 3-methyl-1-butanol and 2-ethyl-1-hexanol. DISCUSSION: The emission and uptake of the aforementioned VOCs disclose potential unexplored metabolic pathways for EC that deserve to be investigated. Overall, we identified new candidate VOC potentially exploitable, upon experimental confirm in in vivo model of disease, as potential biomarkers of sepsis and pro-inflammatory clinical settings.
Authors: B de Lacy Costello; A Amann; H Al-Kateb; C Flynn; W Filipiak; T Khalid; D Osborne; N M Ratcliffe Journal: J Breath Res Date: 2014-01-13 Impact factor: 3.262
Authors: Beatriz Salvador; Alicia Arranz; Sara Francisco; Laura Córdoba; Carmen Punzón; Miguel Ángel Llamas; Manuel Fresno Journal: Pharmacol Res Date: 2016-04-09 Impact factor: 7.658
Authors: Tobias Fink; Alexander Wolf; Felix Maurer; Frederic W Albrecht; Nathalie Heim; Beate Wolf; Anne C Hauschild; Bertram Bödeker; Jörg I Baumbach; Thomas Volk; Daniel I Sessler; Sascha Kreuer Journal: Anesthesiology Date: 2015-01 Impact factor: 7.892
Authors: Ana Rita Lima; Ana Margarida Araújo; Joana Pinto; Carmen Jerónimo; Rui Henrique; Maria de Lourdes Bastos; Márcia Carvalho; Paula Guedes de Pinho Journal: Sci Rep Date: 2018-04-03 Impact factor: 4.379
Authors: Marie Beatriz Cabral; Celine Joy Dela Cruz; Yumika Sato; Glenn Oyong; Ofelia Rempillo; Maria Cecilia Galvez; Edgar Vallar Journal: Int J Environ Res Public Health Date: 2022-07-08 Impact factor: 4.614